{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T08:49:15Z","timestamp":1777798155964,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.05.078","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T10:43:15Z","timestamp":1527244995000},"page":"3890-3893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection"],"prefix":"10.1016","volume":"36","author":[{"given":"Kate E.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Sheppeard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monisha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.078_b0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.078_b0010","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook, 10th ed. (2017 update). Canberra: Australian Government Department of Health; 2017."},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2018.05.078_b0015","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against herpes zoster and postherpetic neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.078_b0020","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.vaccine.2012.08.070","article-title":"Safety of Zostavax\u2122 \u2013 a cohort study in a managed care organization","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2018.05.078_b0025","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.vaccine.2018.05.078_b0030","unstructured":"Public Health England (PHE). Immunisation against infectious disease (July 2013). Shingles (herpes zoster): the green book, chapter 28a. [WWW document]. URL: <https:\/\/www.gov.uk\/government\/publications\/shingles-herpes-zoster-the-green-book-chapter-28a>. [Accessed 20 July 2017]."},{"key":"10.1016\/j.vaccine.2018.05.078_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212688","article-title":"Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient","author":"Costa","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"52","key":"10.1016\/j.vaccine.2018.05.078_b0040","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: a 10 year review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.078_b0045","unstructured":"National Centre for Immunisation Research and Surveillance (NCIRS). Zoster vaccine for Australian adults: NCIRS fact sheet. Sydney: NCIRS; 2016 Oct. [WWW document]. URL: <http:\/\/www.ncirs.edu.au\/assets\/provider_resources\/fact-sheets\/zoster-vaccine-fact-sheet.pdf>. [Accessed 21 March 2017]."},{"key":"10.1016\/j.vaccine.2018.05.078_b0050","unstructured":"U.S. Food & Drug Administration (October 2017). [WWW document]. URL: <https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM581750.pdf>. [Accessed 03 November 2017]."},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.078_b0055","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2018.05.078_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.05.078_b0065","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2018.05.078_b0070","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.078_b0075","unstructured":"GlaxoSmithKline. Study to evaluate efficacy, safety and immunogenicity of GlaxoSmithKline (GSK) Biologicals\u2019 herpes zoster vaccine GSK1437173A. 2018. ClinicalTrials.Gov identifier NCT01610414 on ClinicalTrials.gov. U.S. National Library of Medicine <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01610414> [accessed 25 March 2018]."},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.078_b0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/21645515.2016.1232787","article-title":"Safety and immunogenicity of a herpes zoster subunit vaccine in Japanese population aged \u226550 years when administered subcutaneously vs intramuscularly","volume":"13","author":"Vink","year":"2017","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T02:06:54Z","timestamp":1529028414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":16,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18307448"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}